Lifeline Biotechnologies Inc (LLBO)

[MEAD II]

IMO people need to think this one through. While a lock at 0.05 could serve to raise the ask, it might also buy you out early, since the current market value estimate as of 2016 is estimated at 0.053.

Is your buyout price after waiting through the trials really 0.003 less than the estimated market value as posted on this site's DD at a Glance?

IMO there will be a premium in the marketplace once the FDA Trials are completed.

Also taking into consideration the Holmes holdings of 181.6M+, the buy-out price per share could rise between 0.15 and 0.20 per share which could be purchased in the stock of the acquiring firm. IMO GLTA